Director Declaration
No summary for this filing – the full text is below.
Select text to share a quote on X · sign in to keep highlights & notes in your OXB notes
Oxford, UK - 2 July 2025: OXB (LSE: OXB), a global quality and innovation-led cell and gene therapy CDMO, today announces that Mr. Colin Bond, Independent Non-Executive Director, has been appointed as Additional Director (Non-Executive, Independent) of OneSource Specialty Pharma Limited, a company listed at the National Stock Exchange of India Limited (NSE) and Bombay Stock Exchange Limited (BSE), subject to the approval of the shareholders by way of special resolution expected to be announced on or around 1 August 2025.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.